Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Income Statement [Abstract]
Revenues	$ 6,964	$ 23,703
Operating Expenses:
Cost of revenues	1,283	3,530
Advertising	58,961	29,764
Payroll and related expense	303,850	1,156,914
Stock-based compensation		222,700
Amortization of software costs		38,549
Impairment of software costs		196,315
Allowance for uncollectible advances to COWA Science Corporation (“COWA”)		360,500
Other general and administrative expenses	803,081	1,460,867
Total Operating Expenses	1,167,175	3,469,139
Loss From Operations	(1,160,211)	(3,445,436)
Other Income (Expense):
Interest expense	(5,139,321)	(4,935,470)
Preferred stock issuance costs		(5,585,594)
Change in derivative liability for authorized shares shortfall	(170,319,590)	(18,921,537)
Change in fair value of derivative liabilities	(451,351)	(685,415)
Impairment on investment		(91,931)
Gain on forgiveness of debt	250,000
Gain on settlement of convertible notes payable and accrued interest, warrants and accounts payable	162,109,131
Gain (loss) on conversion of convertible notes	882	(603,529)
Total Other Income (Expense)	(13,550,249)	(30,823,476)
Net Loss Before Income Taxes	(14,710,460)	(34,268,912)
Provision for Income Taxes (Benefit)
Net Loss	(14,710,460)	(34,268,912)
Deemed dividend from warrant price protection	(95,838,488)	(28,933,472)
Deemed dividend resulting from amortization of preferred stock discount	(1,074,539)
Contingent beneficial conversion feature on preferred shares issuance		(45,147,093)
Deemed dividend for issuance of common shares to settle warrant provision		(437,400)
Deemed dividend from exchange of preferred shares for convertible notes		(1,476,280)
Net Loss Available to Common Stockholders	$ (111,623,487)	$ (110,263,157)
Net loss per common share:
Basic (in Dollars per share)	$ (0.08)	$ (0.19)
Diluted (in Dollars per share)	$ (0.08)	$ (0.19)
Weighted average common shares outstanding:
Basic (in Shares)	1,390,934,274	576,802,421
Diluted (in Shares)	1,390,934,274	576,802,421